Research Site 3 — Boston, Massachusetts

Research Site 3 is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site 3 has participated in 1 clinical trials.

Therapeutic areas: T Cell Lymphoma, B Cell Lymphoma, Acute Myeloid Leukemia.

Sponsors: CRISPR Therapeutics.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 3?

Research Site 3 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 3 conducted?

Research Site 3 has 1 clinical trials on record. Their work covers T Cell Lymphoma, B Cell Lymphoma, Acute Myeloid Leukemia.

Is Research Site 3 accredited by Crixeo Health?

Research Site 3 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 3?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.